Anthem Biosciences Limited · NSE: ANTHEM · BSE: 544449

Anthem Biosciences

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 21 Jul 2026.

Q1 FY27 · Consolidated

Revenue
418.22₹ Cr
−22.6% vs year ago
Net profit
119.94₹ Cr
−11.7% vs year ago
EPS, basic
2.13₹
−12.3% vs year ago
Net margin
28.7%
+3.5 pts vs year ago
Revenue₹ crore · consolidated · last 5 quarters
Q1 FY26: ₹540.21 CrQ2 FY26: ₹550.03 CrQ3 FY26: ₹423.15 CrQ4 FY26: ₹610.94 CrQ1 FY27: ₹418.22 CrQ1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · consolidated · last 5 quarters
Q1 FY26: ₹135.79 CrQ2 FY26: ₹173.43 CrQ3 FY26: ₹92.82 CrQ4 FY26: ₹189.76 CrQ1 FY27: ₹119.94 CrQ1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026418.22−22.6%119.94−11.7%2.1321 Jul 2026
Q4 FY26Jan–Mar 2026610.94—189.76—3.3820 May 2026
Q3 FY26Oct–Dec 2025423.15—92.82—1.6505 Feb 2026
Q2 FY26Jul–Sep 2025550.03—173.43—3.0909 Nov 2025
Q1 FY26Apr–Jun 2025540.21—135.79—2.4313 Aug 2025
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026383.84−28.7%102.01−31.2%1.8121 Jul 2026
Q4 FY26Jan–Mar 2026582.50—211.66—3.7720 May 2026
Q3 FY26Oct–Dec 2025416.57—112.12—2.0005 Feb 2026
Q2 FY26Jul–Sep 2025552.23—198.43—3.5409 Nov 2025
Q1 FY26Apr–Jun 2025538.01—148.34—2.6513 Aug 2025

10 filings on record for this company.